ChemicalBook
Chinese Japanese Germany Korea

Topotecan hydrochloride

Anticancer drug Clinical studies Side effects Uses
Topotecan hydrochloride
Topotecan hydrochloride structure
CAS No.
119413-54-6
Chemical Name:
Topotecan hydrochloride
Synonyms
Hycamtin;NSC 609669;SKF-104864A;Levulan-13C;SKFS 104864A;Nogitecan HCl;5-ALA HCl-13C;TOPOTECAN HCL;HYDROCHLORIDE;SKF-S 104864-A
CBNumber:
CB3361775
Molecular Formula:
C23H24ClN3O5
Formula Weight:
457.91
MOL File:
119413-54-6.mol

Topotecan hydrochloride Properties

Melting point:
213-218°C
storage temp. 
Refrigerator
CAS DataBase Reference
119413-54-6(CAS DataBase Reference)

SAFETY

Hazard Codes  T
Risk Statements  25-36/37/38-46
Safety Statements  26-36/37/39-45
HS Code  29420000

Topotecan hydrochloride price More Price(4)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 14129 Topotecan (hydrochloride) ≥98% 119413-54-6 5mg $24 2018-11-13 Buy
Cayman Chemical 14129 Topotecan (hydrochloride) ≥98% 119413-54-6 10mg $34 2018-11-13 Buy
Cayman Chemical 14129 Topotecan (hydrochloride) ≥98% 119413-54-6 25mg $78 2018-11-13 Buy
Cayman Chemical 14129 Topotecan (hydrochloride) ≥98% 119413-54-6 50mg $144 2018-11-13 Buy

Topotecan hydrochloride Chemical Properties,Uses,Production

Anticancer drug

Topotecan hydrochloride is a water-soluble derivative of camptothecin, which is the form of hydrochloride of topotecan. It is successfully developed by the SmithKline Beecham US company, and approved by the FDA in the United States in 1996. Its trade name is Hycamtin. It is applied in the treatment of ovarian cancer (OVC) as the second-line therapy.
In 1999 the US Food and Drug Administration (FDA) has approved topotecan hydrochloride as small cell lung cancer (SCLC) therapeutic drug. It has been available in the UK, Germany, France and other dozens of countries and regions. The Ⅲ clinical trials are ongoing for this medicine which is used to treat non-small cell lung cancer, cervical cancer, myelodysplastic syndrome.
Topotecan hydrochloride can enter the blood brain barrier. It has the same effect of oral and intravenous injection. The drug has low toxicity predictable bone marrow suppression, and other minor non-hematologic toxicity. Currently there are manufacturers, for clinical treatment of small cell lung cancer, ovarian cancer and other tumors.
Topotecan hydrochloride inhibits the activity of topoisomerase I, which is required for DNA replication. After intravenous injection, the product is hydrolyzed in the blood, and excreted by urinary. This product has a rapid serum clearance rate, which is 62L/h. It is widely distributed in vivo, and Its half-lifetime is about 2~3h. Preclinical trials have shown that the product has anti-tumor activity on all kinds of types of tumor. In I clinical trial, to patients with ovarian cancer that is cisplatin tolerance, this product also has significant anti-tumor effect.

Clinical studies

In a open randomized trial, 226 cases who used cisplatin or carboplatin invalid or recurrent advanced ovarian cancer women changed to this product, and compared with paclitaxel. In 112 patients who used topotecan hydrochloride, 22 cases were effective, so the effective rate was 20%. In 114 patients treated with paclitaxel, 14 cases were effective, so the effective rate was 12%. Used this product for treatment which has made significant improvement in the average time of 23 weeks, while 14 weeks for paclitaxel. In a non-controlled trial to 111 women patients with refractory advanced ovarian cancer, 16 cases were preferabe after treatment, occupied with 14%, and the curative effect average time was 16-week, and the average survival time was 52-week. In an open trial, 67 cases were ineffective treated with cisplatin and paclitaxel for advanced ovarian cancer. However, 9 cases who changed to this product were effective, and the effective rate was 13%.
The above information is edited by the chemicalbook of Kui Ming.

Side effects

It can appear toxicity of bone marrow suppression in limited doses, especially it can cause neutropenia. It often induced thrombocytopenia and anemia. Sometimes red blood cell and platelet transfusion is necessary. It can also be nausea, vomiting, hair loss, diarrhea, abdominal pain, gastritis and weakness, but all of them were mild.

Uses

It is used as antineoplastic agent.

Chemical Properties

White Crystalline Solid

Uses

Naturally occurring amino acid; precursor of tetrapyrroles in the biosynthesis of chlorophyll and heme. Antineoplastic (photosensitizer)

Uses

antineoplastic; topoisomerase I inhibitor

Uses

A DNA topoisomerase I inhibitor; semisynthetic analog of Camptothecin. Antineoplastic. Topotecan hydrochloride is a chemotherapy agent that is a topoisomerase 1 inhibitor.

brand name

Topotecan is INN and BAN.

General Description

Topotecan is supplied in 4-mg vials and administered IV forthe treatment of ovarian cancer, cervical cancer, and smallcell lung cancer in those patients who did not respond tofirst-line therapy. Following IV administration, the drug iswidely distributed with 10% to 35% of the agent bound toplasma proteins. There is evidence that the agent may crossthe blood-brain barrier to some extent. In plasma, an equilibriumis established between the lactone and the less activehydroxy acid with 20% of the drug present as the lactone 1hour after the infusion is complete. In contrast to irinotecan,both the lactone and the hydroxy acid bind equally well tohuman serum albumin. N-Demethylation of the tertiaryamine to give the secondary amine is mediated by CYP3A4and represents a minor route of metabolism. Glucuronidationof the parent and the phase I metabolites also occurs to a limited(10%) extent.Elimination occurs primarily in theurine, with 30% of the dose being recovered as unchangeddrug. The terminal elimination half-life is 2 to 3 hours. Themajor toxicity seen for topotecan is dose-limiting myelosuppression.Nausea and vomiting are seen in most (70%–80%)patients, along with diarrhea and abdominal pain. Other toxicitiesinclude headache myalgias, alopecia and elevation ofserum transaminases, alkaline phosphatases, and bilirubin.Microscopic hematuria (blood in the urine) may also be seen.

Topotecan hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products


Topotecan hydrochloride Suppliers

Global( 265)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Shenzhen Sendi Biotechnology Co.Ltd.
0755-23311925 18102838259
0755-23311925 Abel@chembj.com CHINA 3203 55
Henan DaKen Chemical CO.,LTD.
+86-371-55531817
info@dakenchem.com CHINA 21954 58
Henan Tianfu Chemical Co.,Ltd.
0371-55170693
0371-55170693 info@tianfuchem.com CHINA 20680 55
Shanghai Time Chemicals CO., Ltd.
+86-021-57951555
+86-021-57951555 jack.li@time-chemicals.com CHINA 1367 55
Mainchem Co., Ltd.
+86-0592-6210733
+86-0592-6210733 sales@mainchem.com CHINA 32457 55
Nanjing Finetech Chemical Co., Ltd.
025-85710122 17714198479
025-85710122 sales@fine-chemtech.com CHINA 892 55
Biochempartner
0086-13720134139
candy@biochempartner.com CHINA 956 58
Chengdu Biopurify Phytochemicals Ltd.
18080483897
maggie@biopurify.com CHINA 2236 58
Chemwill Asia Co.,Ltd.
86-21-51086038
86-21-51861608 chemwill_asia@126.com;sales@chemwill.com;chemwill@hotmail.com;chemwill@gmail.com CHINA 24001 58
Hubei Jusheng Technology Co.,Ltd.
86-188-71490254
peter@hubeijusheng.com CHINA 20095 58

View Lastest Price from Topotecan hydrochloride manufacturers

Image Release date Product Price Min. Order Purity Supply Ability Manufacturer
2018-12-23 Topotecan hydrochloride
119413-54-6
US $2.00 / kg 1kg 99% 100kg career henan chemical co

119413-54-6(Topotecan hydrochloride)Related Search:


  • Hycamtin
  • Nogitecan hydrochloride
  • Topotecan hydrochloride
  • (S)-10-((diMethylaMino)Methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride
  • 2-Aza-bicyclo[4.1.0]heptane(HCl):2-Aza-bicyclo[4.1.0]heptane
  • (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, hydrochloride (1:1)
  • Nogitecan HCl
  • Topotecan Hydrochloride Labeled d6
  • Topotecan hydrochloride, >=99%
  • N-(oxolan-2-ylmethyl)-2-(propan-2-ylamino)acetamide
  • 2-[5-(1-ethylpyrazol-4-yl)-1,3,4-oxadiazol-2-yl]ethanamine
  • (1S,5R)-3,3-difluoro-8-azabicyclo[3.2.1]octane
  • TOPOTECAN MONOHYDROCHLORIDE
  • TOPOTECAN HCL
  • SKF-104864A
  • 9-[(DIMETHYLAMINO)METHYL]-10-HYDROXY-(20S)-CAMPTOTHECIN, HCL
  • (4S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4',6-7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE
  • HYDROCHLORIDE
  • topetecan hydrochloride
  • 5-PIPERAZIN-1-YL-BENZOFURAN-2-CARBOXYLIC ACID ETHYL ESTER
  • (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[346-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Hydrochloride, SKF-104864A,
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, monohydrochloride, (4S)- (9CI)
  • 5-ALA HCl-13C
  • 5-Amino-4-oxopentanoic Acid-13C
  • 5-Aminolevulinic Acid-3-13C Hydrochloride
  • Aminolevulinic-13C Acid Hydrochloride
  • d-Aminolevulinic-13C Acid Hydrochloride
  • Levulan-13C
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, monohydrochloride, (S)-
  • NSC 609669
  • SKFS 104864A
  • SKF-S 104864-A
  • Topotecan Hydrochloride(TECANS)
  • (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride
  • (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3’,4’,6-7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Hydrochloride
  • 1,4-di[4-(3-phenoxypropoxy)-2-butynyl]piperazine
  • 1,4-di(4-benzhydryloxy-2-butynyl)piperazine
  • 1,4-di(4-benzyloxy-2-butynyl)piperazine
  • (S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-(H-Pyrano[3' , 4':6,7]indolizino[1,2-b]quinoline-3,14[4H,12H]-dione monohydrochloride
  • Topotecan Hydrochloride(TPT)
  • S-(6-thioxo-1,6-dihydro-pyrimidin-4-yl)-isothiourea
  • Topotecan hydrochloride(NSC-609699)
  • Topotecan, Hydrochloride Salt
  • Toputecan hydrochloride
  • 2-Methyl-4-piperidino-butan-2-ol
  • Topotecan HCl (HycaMtin)
  • 3-Methoxy-5-Methyl-4-MethylaMino-heptanoic acid tert-butyl ester
  • [2-(4-Methyl-piperazin-1-yl)-ethyl]-carbamic acid tert-butyl ester
  • Topotecan hydrocloride
  • Topotecan (Nogitecan) HCl
  • (3,5-Dimethoxy-phenyl)-(1H-pyrazol-3-ylmethyl)-amine
  • (2S)-2-[[(2R)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanamide
  • 1,1-Dimethyl-2-(2-oxo-2-phenyl-ethyl)-isothiourea
  • Benzyl-[1-(2-chloro-ethyl)-piperidin-3-yl]-amine
  • 1-Methyl-4-(toluene-4-sulfonyl)-piperazine
  • 1-Methyl-2-(3-methyl-pyrazol-1-yl)-ethylamine
  • 4,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline
  • 5-bromo-7-methoxy-1,2,3,4-tetrahydroisoquinoline-4,6-diol
Copyright 2017 © ChemicalBook. All rights reserved